Douglas Lane & Associates
Douglas Lane & Associates reported 246 stocks worth $7.5B in its 13F filing for Q3 2026, filed Oct 9, 2026. Its largest holdings are NVDA (4.4%), GOOG (3.4%) and MRNA (3.0%). Compared with Q2 2026, the fund opened new positions in XOM, added to NSRGY, CRM and BA, trimmed NVDA, GOOG and MRNA and sold out of XOM, CMI and LHX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  NVDA Nvidia Corporation | $327M | 4.4% | 1.4M | −73K (−5%) | 8 of 8 | |
| 2 |  GOOG Alphabet Inc | $251M | 3.4% | 738K | −30K (−4%) | 8 of 8 | |
| 3 |  MRNA Moderna Inc | $224M | 3.0% | 1.2M | −183K (−14%) | 8 of 8 | |
| 4 |  JPM Jpmorgan Chase & Co. | $183M | 2.5% | 553K | −28K (−5%) | 8 of 8 | |
| 5 |  MSFT Microsoft Corp | $172M | 2.3% | 335K | −7,155 (−2%) | 8 of 8 | |
| 6 |  JNJ Johnson & Johnson | $170M | 2.3% | 644K | −20K (−3%) | 8 of 8 | |
| 7 |  QCOM Qualcomm Inc | $153M | 2.0% | 831K | −9,844 (−1%) | 8 of 8 | |
| 8 |  TMO Thermo Fisher Scientific Inc | $146M | 2.0% | 217K | −5,041 (−2%) | 8 of 8 | |
| 9 |  AMZN Amazon Com Inc | $132M | 1.8% | 531K | No change | 8 of 8 | |
| 10 |  MS Morgan Stanley | $127M | 1.7% | 677K | −55K (−7%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 XOM Exxon Mobil Corp | $61.4M | 449K |
 CMI Cummins Inc | $469K | 657 |
 LHX L3HARRIS Technologies in | $280K | 963 |
 CARR Carrier Global Corporation | $279K | 3,810 |
 CEG Constellation Energy Cor | $268K | 1,080 |
🔒 Free account: see all 11.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Oct 9, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Douglas Lane & Associates 13F FAQ
What does Douglas Lane & Associates own?
Douglas Lane & Associates reported 246 stocks worth $7.5B in its 13F filing for Q3 2026, filed Oct 9, 2026. Its largest holdings are NVDA (4.4%), GOOG (3.4%) and MRNA (3.0%). The table above lists every position in the filing (the top 10 without an account).
What did Douglas Lane & Associates buy and sell in Q3 2026?
Compared with Q2 2026: 7 new positions, 47 added to, 169 trimmed and 11 sold out. New positions include XOM. It sold all of XOM, CMI and LHX.
When will Douglas Lane & Associates file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Douglas Lane & Associates's portfolio worth?
The Q3 2026 filing reports $7.5B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.